| Literature DB >> 16641899 |
H Ninomiya1, K Nomura, Y Satoh, S Okumura, K Nakagawa, M Fujiwara, E Tsuchiya, Y Ishikawa.
Abstract
To investigate what kind of genetic instability plays important roles in lung carcinogenesis, we analyzed micro- and minisatellite instability, loss of heterozygosity (LOH) and chromosome instability in 55 cases of lung cancer, including, 10 squamous cell, 5 large cell, and 3 small cell carcinomas, and 37 adenocarcinomas. Analysis of minisatellite instability, the mechanism of which is different from microsatellite instability, has not been reported previously. Minisatellite instability was detected in only one case (1/55, 1.8%), and the frequency of microsatellite instability was low, being found only in three cases (3/55, 5.5%). In contrast, LOH, for at least in one locus, was observed in 27 cases (49.1%). In adenocarcinomas, the frequency of LOH was higher in poorly differentiated compared to more differentiated carcinomas. For chromosome instability, a similar correlation between differentiation grade and instability was observed in adenocarcinomas. And instability was more common in large cell and small cell carcinomas than in adenocarcinomas. Our analysis showed that chromosome instability and LOH, rather than mini- and microsatellite instability, play significant roles in the development of lung cancer.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16641899 PMCID: PMC2361274 DOI: 10.1038/sj.bjc.6603121
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Clinical characteristics of patients
|
| |||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| w/d AC | 8 : 11 | 62.9 | 9 | 2 | 5 | 2 | 359±574 |
| m/d AC | 3 : 7 | 60.4 | 3 | 1 | 6 | 0 | 414±563 |
| p/d AC | 6 : 2 | 64.3 | 3 | 1 | 3 | 1 | 619±503 |
| SCC | 9 : 1 | 66.9 | 6 | 0 | 4 | 0 | 1656±879 |
| LCC | 5 : 0 | 61.9 | 5 | 0 | 0 | 0 | 1327±563 |
| SCLC | 3 : 0 | 67.7 | 2 | 1 | 0 | 0 | 775±288 |
AC, adenocarcinoma; SCC, squamous cell carcinoma; LCC, large cell carcinoma; SCLC, small cell lung carcinoma; smoking index, (number of cigarettes per day) × (duration of years); w/d, well differentiated; m/d, moderately differentiated; p/d, poorly differentiated.
Figure 1Representation of mini- and microsatellite instability and LOH. (A) Minisatellite instability at marker D1S80 (*Case 15 of well differentiated adenocarcinoma.). (B) Microsatellite instability at marker TP53 (**Case 2 of SCLC.). (C) LOH at marker D17S30 (***Case 6, ****Case 7 of poorly differentiated adenocarcinoma.) Arrows: alteration allele; T: tumour; N: normal tissue.
Figure 2Comparison of frequency of genetic instability.
Results of mini- and microsatellite instability, loss of heterozygosity and chromosome instability
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| AC, well | ||||||||||
| 1 | − | − | − | − | − | − | − | − | − | 0 |
| 2 | − | − | − | − | − | NI | − | − | − | 0 |
| 3 | − | − | − | − | NI | NI | − | − | NI | 0 |
| 4 | − | − | − | − | − | NI | −LOH | − | − | 0 |
| 5 | − | − | − | − | NI | − | − | − | − | L |
| 6 | − | − | − | − | − | NI | − | − | − | H |
| 7 | − | − | − | − | − | − | − | − | − | L |
| 8 | − | − | − | − | − | NI | − | − | − | − |
| 9 | − | − | − | − | NI | − | −LOH | − | − | M |
| 10 | − | NA | −LOH | − | − | − | − | − | − | 0 |
| 11 | − | − | − | − | NI | − | − | − | NI | 0 |
| 12 | − | − | − | NI | − | NI | − | − | NI | 0 |
| 13 | − | − | − | − | − | − | − | − | −LOH | M |
| 14 | − | − | − | − | − | NI | − | − | − | 0 |
| 15 | + | + | −LOH | + | + | NI | +LOH | −LOH | +LOH | M |
| 16 | − | − | − | − | − | − | − | − | − | NP |
| 17 | − | − | − | − | − | − | − | − | − | M |
| 18 | − | − | − | − | − | NI | − | − | − | NP |
| 19 | − | − | − | − | − | − | − | − | − | NP |
| AC, mod | ||||||||||
| 1 | − | − | − | − | NI | − | − | − | − | − |
| 2 | − | − | − | − | − | − | − | − | − | − |
| 3 | − | − | − | − | −LOH | −LOH | −LOH | −LOH | − | 0 |
| 4 | − | − | − | − | NI | − | − | − | − | 0 |
| 5 | − | − | − | − | − | NI | −LOH | −LOH | NI | M |
| 6 | − | − | − | − | − | − | − | − | − | 0 |
| 7 | − | − | − | − | NI | − | −LOH | − | − | 0 |
| 8 | − | − | − | − | −LOH | − | − | − | −LOH | − |
| 9 | − | − | − | − | − | −LOH | − | − | − | 0 |
| 10 | − | − | − | − | + | NI | −LOH | −LOH | −LOH | M |
| AC, por | ||||||||||
| 1 | − | − | − | −LOH | −LOH | − | − | −LOH | −LOH | M |
| 2 | − | − | − | NI | − | NI | −LOH | −LOH | − | M |
| 3 | − | − | − | − | − | NI | − | − | − | M |
| 4 | − | − | − | − | − | − | − | − | − | 0 |
| 5 | − | − | − | − | − | − | − | − | − | NP |
| 6 | − | − | −LOH | − | NI | − | −LOH | − | NI | H |
| 7 | − | − | −LOH | − | − | − | − | − | − | M |
| 8 | − | − | − | − | − | − | −LOH | −LOH | −LOH | − |
| SCC | ||||||||||
| 1 | − | − | − | − | − | − | − | −LOH | N−I | H |
| 2 | − | − | − | − | − | − | − | − | NI | 0 |
| 3 | − | − | − | − | − | NI | − | − | − | 0 |
| 4 | − | − | − | − | NI | − | − | − | − | 0 |
| 5 | − | − | − | − | − | − | −LOH | − | − | M |
| 6 | − | − | − | − | NI | − | −LOH | − | − | H |
| 7 | − | − | − | − | − | NI | − | − | − | H |
| 8 | − | − | − | − | −LOH | NI | − | − | − | H |
| 9 | − | − | − | − | − | − | − | − | − | 0 |
| 10 | − | − | − | − | − | − | NI | − | − | NP |
| LCC | ||||||||||
| 1 | − | − | − | − | −LOH | − | − | − | − | H |
| 2 | − | − | − | − | − | − | − | − | − | 0 |
| 3 | − | − | − | − | − | − | −LOH | − | − | NP |
| 4 | − | − | − | − | −LOH | − | −LOH | −LOH | −LOH | M |
| 5 | − | − | − | − | − | − | −LOH | −LOH | −LOH | H |
| SCLC | ||||||||||
| 1 | − | NA | − | − | −LOH | −LOH | NI | −LOH | −LOH | M |
| 2 | − | − | − | − | −LOH | −LOH | + | −LOH | −LOH | H |
| 3 | − | − | − | − | − | NI | −LOH | − | NI | M |
Frequencies of mini- and microsatellite instability
|
|
| |||
|---|---|---|---|---|
|
|
|
|
|
|
| w/d AC | 1 | Apo-B, D1S80 | 1 | TP53, D3S1067,D17S786, AFM184Xe |
| m/d AC | 0 | 1 | D3S1067 | |
| p/d AC | 0 | 0 | ||
| SCC | 0 | 0 | ||
| LCC | 0 | 0 | ||
| SCLC | 0 | 1 | TP53 | |
| No. of total (total%) | 1/55(1.8%) | 3/55(5.5%) | ||
No.: number
Minisatellite markers: Apo-B, D17S30, D1S80
Microsatellite markers: TP53, HPOCA3, D3S1067, D13S270, D17S786, AFM184Xe,
AC: adenocarcinoma; SCC: squamous cell carcinoma; LCC: large cell carcinoma; SCLC, small cell lung carcinoma; w/d, well differentiated; m/d, moderately differentiated; p/d, poorly differentiated.
Histological subtypes and frequency of loss of heterozygosity and FAL
|
| ||||||||
|---|---|---|---|---|---|---|---|---|
|
| 0 | 1 | 2 | 3 | 4 |
|
|
|
| w/d AC | 14 | 4 | 0 | 0 | 1 | 5 | 26.3 | 0.053±0.090 |
| m/d AC | 4 | 2 | 2 | 1 | 1 | 6 | 60.0 | 0.180±0.199 |
| p/d AC | 3 | 1 | 2 | 1 | 1 | 5 | 62.5 | 0.188±0.201 |
| SCC | 6 | 4 | 0 | 0 | 0 | 4 | 40.0 | 0.085±0.111 |
| LCC | 1 | 2 | 0 | 1 | 1 | 4 | 80.0 | 0.160±0.167 |
| SCLC | 0 | 1 | 0 | 0 | 2 | 3 | 100.0 | 0.483±0.202 |
LOH, loss of heterozygosity; no., number; Total (%), number of LOH/number of informative cases; FAL, fractional allelic loss, no. of positive/total of adenocarcinoma.
Number of loss of heterozygosity and the loci of mini- and microsatellite markers
|
|
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
| |
| Total no. of LOH | 0 | 0 | 4 | 1 | 8 | 4 | 16 | 12 | 10 |
| No. of NI | 0 | 0 | 0 | 2 | 10 | 17 | 2 | 0 | 8 |
| LOH/informative cases (%) | 0.0 | 0.0 | 7.3 | 1.9 | 17.8 | 10.5 | 30.2 | 21.8 | 21.3 |
LOH, loss of heterozygosity; no, number; NI, not informative cases (One case of well-differentiated adenocarcinoma was not examined at the locus of Apo-B).
Figure 3Typical karyotype of squamous cell carcinoma (Case 6); 67∼71<2n>,X,−Y,del(1)(p22),+del(1)(q32),+2,+2,+add(6)(q21) × 2,+7,+add(7)(p15) × 2,+8,+11,+11,+del(12)(q22) × 2,+13,add(14)(p13) × 2,−15,+17,+i(17)(q10),+18,+18,+20,+mar1 × 2,+4∼10mar[cp6].
Histological subtypes and the grade of chromosome instability
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| w/d AC | 8 | 2 | 4 | 1 | 4 | |
| 53.3% | 13.3% | 26.7% | 6.7% | 33.4% | ||
| m/d AC | 5 | 0 | 2 | 0 | 3 | |
| 71.4% | 0.0% | 28.6% | 0.0% | 28.6% | ||
| p/d AC | 1 | 0 | 4 | 1 | 2 | |
| 16.7% | 0.0% | 66.7% | 16.7% | 83.4% | ||
| SCC | 4 | 0 | 1 | 4 | 1 | |
| 44.4% | 0.0% | 11.1% | 44.4% | 55.5% | ||
| LCC | 1 | 0 | 1 | 2 | 1 | |
| 25.0% | 0.0% | 25.0% | 50.0% | 75.0% | ||
| SCLC | 0 | 0 | 2 | 1 | 0 | |
| 0.0% | 0.0% | 66.7% | 33.3% | 100.0% |
Grading according to the number of structural alterations: L, low less than 5; M,moderate 6-15; H, high more than 16; NP, not proliferative; no., number; AC, adenocarcinoma; SCC, squamous cell carcinoma; LCC, large cell carcinoma; SCLC, small cell lung carcinoma; w/d, well differentiated; m/d, moderately differentiated; p/d, poorly differentiated.